Our Mission & Vision

NEOnatal PHArmacological STudies at AI-powered speed.

Neonatal research faces unique challenges: limited therapeutic options, ethical constraints, and complex physiological differences. Traditional preclinical models often fail to predict neonatal responses accurately.

Neophast bridges this gap by providing validated, ethical, and predictive neonatal models powered by artificial intelligence, enabling safer and more effective therapeutic development for our most vulnerable patients.

A small company delivering big solutions in neonatal preclinical models.


Revolutionary Neonatal Models

AI-Enhanced Precision

Machine learning algorithms analyse complex neonatal physiological patterns, improving predictive accuracy by 40% compared to traditional models.

Validated & Ethical

Our models undergo rigorous validation protocols whilst maintaining the highest ethical standards, ensuring reliable results without compromising patient welfare.

Translational Focus

Designed specifically for research pharmaceutical development, our models accelerate the path from laboratory discovery to clinical application in neonatal care.

Expert Entrepreneurial Team

Dr. José Martínez-Orgado

Chief Scientific Officer

Leading neonatologist with over 30 years of clinical and research experience. Pioneer in neonatal neuroprotection and translational medicine at Hospital Clínico San Carlos.

Dr. Merari Tumin Chevalier

Chief Executive Officer

Scientific entrepreneur. Combines technological and scientific rigour with strategic business acumen to drive innovation in medical research and development.

Dr. Luis Arruza

Chief Technolgy Officer

Neonatologist with high expertise in neonatal intensive care. Expert in preclinical modeling development with extensive experience at Hospital Clínico San Carlos.


Partner with Neophast

Universities & Research Centres

Accelerate your neonatal research with validated models and AI-powered analytics. Access cutting-edge tools for breakthrough discoveries.

Pharmaceutical Companies

Reduce development timelines and costs with predictive neonatal models. Ensure safer, more effective therapeutics for paediatric populations.

Start Collaboration

Keep up to date with our latest news!